March 26, 2024
While CRISPR has shown immense promise as a next-generation therapeutic tool, the gene editing technology’s edits are still imperfect. Researchers have developed a new genetic system to test and analyze CRISPR-based DNA repair and related risks from unintended but harmful “bystander” edits.
June 2, 2021
Scientists have developed a gene drive with a built-in genetic barrier that is designed to keep the drive under control. The researchers engineered synthetic fly species that, upon release in sufficient numbers, act as gene drives that can spread locally and be reversed if desired.
May 11, 2017
…Diego’s commitment to diversity, healthy and sustainable practices and greater San Diego community involvement and presence in business. Singleton leads the Small Business Development Office in hosting annual supplier diversity expos, business conferences and workshops that increase networking and performance opportunities for small diverse businesses. Additionally, in partnership with the…
February 8, 2023
With a generous $22 million in gifts from Joan and Irwin Jacobs, UC San Diego Health will bring its Center for Health Innovation into full reality.
October 27, 2017
Researchers at the University of California San Diego School of Medicine, with colleagues in Brazil, report that the Zika virus is transmitted from mother to fetus by infected cells that, ironically, will later develop into the brain’s first and primary form of defense against invasive pathogens.
August 25, 2021
Stem cell models derived from people with specific genomic variation recapitulate aspects of their autism spectrum disorder, providing a valuable model to study the condition and look for therapeutic interventions.
June 10, 2021
…action to improve mental health among graduate students, launched a sorority dedicated to the Black student experience and forged a new art collective that embraces identity. And their impact was not confined to the borders of the university. They explored how Syrian women leverage art as a form of revolution…
August 3, 2020
UC San Diego researchers discovered that people with an inactive RNA-editing enzyme respond better to cancer immunotherapy, and inhibitors of the enzyme help mice with difficult-to-treat cancers live longer.
July 30, 2020
Researchers at UC San Diego School of Medicine and Moores Cancer Center report that an investigational drug candidate called tipifarnib showed promise in treating key recurring mutation in head and neck cancers.
August 14, 2012
The UC San Diego Foundation has announced that 10 new community and business leaders, including four alumni of the University of California, San Diego, will join its Board of Trustees for the 2012-2013 fiscal year.
